Unlearn AI is a California-based company that specializes in the development and deployment of AI technology to accelerate clinical drug development and improve treatment outcomes in medicine. Their approach focuses on using generative machine learning methods to predict individual health outcomes and simulate potential futures by creating patient digital twins. These digital twins enable Unlearn AI to forecast how a patient's health may change over time, compare potential health outcomes, and estimate relative treatment effects. The company partners with innovators in the pharma and biotech industry to accelerate clinical drug development and achieve full enrollment in AI-powered clinical trials faster. Unlearn AI's main application is in AI-powered clinical trials where their digital twins can simulate various scenarios to compare the potential health outcomes of different treatments. Overall, Unlearn AI's mission is to advance AI technology to ultimately eliminate the trial and error process and improve treatment outcomes in medicine, taking a patient-centric approach to personalized medicine.
TLDR: AI for Personalized medicine prediction for clinical trials. Copy and paste these prompts into Unlearn.